{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:10:05Z","timestamp":1785406205998,"version":"3.56.0"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1097\/dss.0000000000003050","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T14:53:43Z","timestamp":1619448823000},"page":"1119-1121","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Intratumoral Interleukin-2 Injections Without Systemic Therapy for Isolated Cutaneous Metastatic Breast Cancer"],"prefix":"10.1097","volume":"47","author":[{"given":"Benjamin G.","family":"Gorman","sequence":"first","affiliation":[{"name":"Mayo Clinic Alix School of Medicine, Minnesota Campus, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Jakub","sequence":"additional","affiliation":[{"name":"Breast, Endocrine, Metabolic, and Gastrointestinal Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Hobday","sequence":"additional","affiliation":[{"name":"Medical Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry D.","family":"Brewer","sequence":"additional","affiliation":[{"name":"Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"R1-20250731","first-page":"001356","article-title":"A first sign not to be missed: cutaneous metastasis from breast cancer","volume":"7","author":"Araujo","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/sj.bjc.6601320","article-title":"Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases","volume":"89","author":"Radny","year":"2003","journal-title":"Br J Cancer"},{"key":"R3-20250731","first-page":"491","article-title":"Intralesional injection of interleukin-2-expanded autologous lymphocytes in melanoma and breast cancer patients: a pilot study","volume":"3","author":"Adler","year":"1984","journal-title":"J Biol Response Mod"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.gt.3300833","article-title":"Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial","volume":"6","author":"Stewart","year":"1999","journal-title":"Gene Ther"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"CT040","DOI":"10.1158\/1538-7445.AM2019-CT040","article-title":"Abstract CT040: a phase I trial of talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer","volume":"79","author":"Soliman","year":"2019","journal-title":"Cancer Res"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:13:51Z","timestamp":1754000031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003050","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]}}}